Skip to main content
. 2013 Jul 22;142(4):714–723. doi: 10.1017/S0950268813001684

Table 3.

Selected demographic and clinical characteristics of tested patients, by laboratory confirmation status, Poland, July 2009–April 2011

Negative (n = 944) Confirmed by PCR (n = 10) Confirmed by ELISA (n = 278)
Age group (years), n (%)
 3–19 265 (28·1) 3 (30·0) 61 (21·9)
 20–39 267 (28·3) 5 (50·0) 58 (20·9)
 40–59 250 (26·5) 0 88 (31·7)
 ⩾60 162 (17·2) 2 (20·0) 71 (25·5)
Sex, n (%)
 Male 347 (36·8) 0 114 (41·0)
 Female 597 (63·2) 10 (100·0) 164 (59·0)
Duration of cough in days, mean (s.d.) 31·9 (18·4) 26·4 (22·5) 35·4 (19·3)
Type of cough, n (%)
 Paroxysms 916 (97·0) 10 (100·0) 264 (95·0)
 Mainly at night 522 (55·3) 6 (60·0) 161 (57·9)
 Whoops 140 (14·8) 1 (10·0) 62 (22·3)
 Apnoea 283 (30·0) 4 (40·0) 85 (30·6)
Concomitant symptoms, n (%)
 Fever 206 (23·4) 1 (10·0) 59 (22·5)
 Accompanied by vomiting 132 (15·0) 0 36 (13·7)
 Wheezing 173 (19·6) 0 55 (21·0)
 Aphagia 82 (9·3) 0 24 (9·2)
 Anorexia 36 (4·1) 0 14 (5·3)
Vaccinated against pertussis, n (%)
 >10 years before symptom onset 88 (10·0) 1 (10·0) 31 (11·8)
 5–10 years before onset 33 (3·7) 0 13 (5·0)
 <5 years before onset 156 (17·7) 2 (20·0) 20 (7·6)
Current smoker, n (%)
 <10 cigarettes/day 71 (8·0) 1 (10·0) 25 (9·5)
 10–20 cigarettes/day 72 (8·2) 0 31 (11·8)
 >20 cigarettes/day 23 (2·6) 0 8 (3·1)